Comparison between Bafna Pharmaceuticals IPO and Gokul Refoils IPO.
Bafna Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Gokul Refoils IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the Gokul Refoils IPO is up to ₹139.59 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of Gokul Refoils IPO is ₹195.00 per share.
| Bafna Pharmaceuticals IPO | Gokul Refoils IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹175.00 per share | |
| Issue Price (Upper) | ₹195.00 per share | |
| Issue Price (Final) | ₹40.00 per share | ₹195.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 35 shares | |
| Fresh Issue Size | 64,00,206 shares | 71,58,392 shares |
| Fresh Issue Size (Amount) | up to ₹25.60 Cr | up to ₹139.59 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 64,00,206 shares | 71,58,392 shares |
| Issue Size Total (Amount) | up to ₹25.60 Cr | up to ₹139.59 Cr |
Bafna Pharmaceuticals IPO opens on May 27, 2008, while Gokul Refoils IPO opens on May 08, 2008. The closing date of Bafna Pharmaceuticals IPO and Gokul Refoils IPO is May 30, 2008, and May 13, 2008, respectively.
| Bafna Pharmaceuticals IPO | Gokul Refoils IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 27, 2008 | May 08, 2008 |
| Issue Close | May 30, 2008 | May 13, 2008 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jun 27, 2008 | Jun 04, 2008 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bafna Pharmaceuticals IPO P/E ratio is , as compared to Gokul Refoils IPO P/E ratio of .
| Bafna Pharmaceuticals IPO | Gokul Refoils IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 71.07 | 95.74 | ||||
| Promoter Shareholding (Post-Issue) | 42.6 | 69.76 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹63.92 Cr. | ₹514.39 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 10.65 | 20 |
In the Bafna Pharmaceuticals IPO Retail Individual Investors (RII) are offered 32,00,000 shares while in Gokul Refoils IPO retail investors are offered 32,00,000 shares. Qualified Institutional Buyers (QIB) are offered in Bafna Pharmaceuticals IPO and 35,41,696 shares in Gokul Refoils IPO.
| Bafna Pharmaceuticals IPO | Gokul Refoils IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 35,41,696 shares | |
| NII | 32,00,000 shares | 10,62,508 shares |
| RII | 32,00,000 shares | 24,79,188 shares |
| Employee | 75,000 shares | |
| Others | ||
| Total | 64,00,000 shares | 71,58,392 shares |
Bafna Pharmaceuticals IPO subscribed 4.88x in total, whereas Gokul Refoils IPO subscribed 4.27x.
| Bafna Pharmaceuticals IPO | Gokul Refoils IPO | |
|---|---|---|
| QIB (times) | 2.72x | |
| NII (times) | 1.57x | 6.58x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 8.20x | 5.59x |
| Employee (times) | 1.06x | |
| Other (times) | ||
| Total (times) | 4.88x | 4.27x |
